Evidence map›Paper›PMID 42534886›Full record

ReviewFrontiers in public health2026

Governing antimicrobial resistance through One Health: a comparative analysis of public health governance in China and the United Kingdom.

Zihan Cai, Hua He, Hua Wu, Jinxin Zhao, Guanghui Zhang, Jiabao Xing

Abstract readComparative StudyReview
In one paragraph

Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zihan CaiSchool of Government, University of Birmingham, Birmingham, United Kingdom.
Hua HeDepartment of Pharmacology and Toxicology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.
Hua WuDepartment of Pharmacology and Toxicology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.
Jinxin ZhaoDepartment of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
Guanghui ZhangDepartment of Pharmacology and Toxicology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.
Jiabao XingSchool of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) has emerged as one of the most pressing threats to global health and a major challenge for contemporary public health governance. As the drivers of AMR span human, animal, and environmental systems, the One Health framework has become central to the design of effective containment strategies. This study compares AMR governance in China and the United Kingdom (UK), focusing on institutional organization, regulatory frameworks, surveillance systems, and mechanisms for cross-sectoral coordination. The analysis highlights two contrasting governance models within the broader One Health paradigm. China relies on strong state-led coordination and hierarchical administrative mobilization, whereas the UK emphasizes specialized institutional collaboration supported by integrated surveillance infrastructures. Despite these structural differences, both countries continue to face major challenges in environmental surveillance, intersectoral data integration, and long-term coordination across sectors. Future progress in AMR control will depend not only on strengthening multisectoral governance capacity, but also on improving the integration of environmental dimensions into existing surveillance and response systems. The comparative experiences of China and the UK offer broader insights into the development of adaptive and globally coordinated One Health strategies for AMR governance.

Indexed as

Drug Resistance, MicrobialOne HealthPublic HealthPublic Health AdministrationChinaHumansPublic Health InfrastructureUnited Kingdomantimicrobial resistanceChinanational action plansOne Healthpublic health administrationUnited Kingdom

Identifiers

PMID42534886
PMCPMC13422482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.